Global Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Region: Trend Forecast and Growth Opportunity

September 2020 | 173 pages | ID: G3A508B1D16CEN
GMD Research

Abstracts

Global pharmaceutical continuous manufacturing market will reach $2,665.5 million by 2030, growing by 10.5% annually over 2020-2030 driven by advantages offered by continuous manufacturing process such as cost saving and improved productivity.

Highlighted with 85 tables and 76 figures, this 173-page report “Global Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Integrated Continuous Systems

Semi-Continuous Systems

• Continuous Granulators
• Continuous Blenders
• Continuous Compressors
• Continuous Coaters
• Continuous Dryers
• Other Semi-Continuous Systems

Controls & Software

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

End Product Manufacturing

• Solid Dosage Manufacturing
• Liquid Dosage Manufacturing

API Manufacturing

Based on End User, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Pharmaceutical Companies
• Contract Manufacturing Organizations
• Research Organizations and Institutes
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product, Technology, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT

3.1 Market Overview by Product
3.2 Integrated Continuous Systems
3.3 Semi-Continuous Systems
  3.3.1 Continuous Granulators
  3.3.2 Continuous Blenders
  3.3.3 Continuous Compressors
  3.3.4 Continuous Coaters
  3.3.5 Continuous Dryers
  3.3.6 Other Semi-Continuous Systems
3.4 Controls & Software

4 SEGMENTATION OF GLOBAL MARKET BY APPLICATION

4.1 Market Overview by Application
4.2 End Product Manufacturing
  4.2.1 Solid Dosage Manufacturing
  4.2.2 Liquid Dosage Manufacturing
4.3 API Manufacturing

5 SEGMENTATION OF GLOBAL MARKET BY END USER

5.1 Market Overview by End User
5.2 Pharmaceutical Companies
5.3 Contract Manufacturing Organizations
5.4 Research Organizations and Institutes
5.5 Other End Users

6 SEGMENTATION OF GLOBAL MARKET BY REGION

6.1 Geographic Market Overview 2019-2030
6.2 North America Market 2019-2030 by Country
  6.2.1 Overview of North America Market
  6.2.2 U.S.
  6.2.3 Canada
  6.2.4 Mexico
6.3 European Market 2019-2030 by Country
  6.3.1 Overview of European Market
  6.3.2 Germany
  6.3.3 UK
  6.3.4 France
  6.3.5 Spain
  6.3.6 Italy
  6.3.7 Russia
  6.3.8 Rest of European Market
6.4 Asia-Pacific Market 2019-2030 by Country
  6.4.1 Overview of Asia-Pacific Market
  6.4.2 Japan
  6.4.3 China
  6.4.4 Australia
  6.4.5 India
  6.4.6 South Korea
  6.4.7 Rest of APAC Region
6.5 South America Market 2019-2030 by Country
  6.5.1 Argentina
  6.5.2 Brazil
  6.5.3 Chile
  6.5.4 Rest of South America Market
6.6 MEA Market 2019-2030 by Country
  6.6.1 UAE
  6.6.2 Saudi Arabia
  6.6.3 South Africa
  6.6.4 Other National Markets

7 COMPETITIVE LANDSCAPE

7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles
ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.

8 INVESTING IN GLOBAL MARKET: RISK ASSESSMENT AND MANAGEMENT

8.1 Risk Evaluation of Global Market
8.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Pharmaceutical Continuous Manufacturing Market, 2019-2030
Table 2. Growth Rate of World Real GDP, 2017-2021
Table 3. Main Product Trends and Market Opportunities in Global Pharmaceutical Continuous Manufacturing Market
Table 4. Global Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 5. Global Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems by Type, 2019-2030, $ mn
Table 6. Global Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 7. Global Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing by Type, 2019-2030, $ mn
Table 8. Global Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 9. Global Pharmaceutical Continuous Manufacturing Market by Region, 2019-2030, $ mn
Table 10. Total Health Expenditure per capita in PPP International U.S. Dollars by Country
Table 11. Leading National Pharmaceutical Continuous Manufacturing Market, 2019 and 2030, $ mn
Table 12. North America Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn
Table 13. U.S. Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 14. U.S. Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 15. U.S. Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 16. Canada Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 17. Canada Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 18. Canada Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 19. Mexico Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 20. Mexico Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 21. Mexico Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 22. Europe Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn
Table 23. Germany Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 24. Germany Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 25. Germany Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 26. UK Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 27. UK Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 28. UK Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 29. France Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 30. France Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 31. France Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 32. Spain Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 33. Spain Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 34. Spain Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 35. Italy Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 36. Italy Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 37. Italy Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 38. Russia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 39. Russia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 40. Russia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 41. Pharmaceutical Continuous Manufacturing Market in Rest of Europe by Country, 2019-2030, $ mn
Table 42. APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn
Table 43. Japan Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 44. Japan Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 45. Japan Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 46. China Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 47. China Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 48. China Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 49. Australia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 50. Australia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 51. Australia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 52. India Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 53. India Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 54. India Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 55. South Korea Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 56. South Korea Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 57. South Korea Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 58. Pharmaceutical Continuous Manufacturing Market in Rest of APAC by Country, 2019-2030, $ mn
Table 59. South America Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn
Table 60. Argentina Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 61. Argentina Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 62. Argentina Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 63. Brazil Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 64. Brazil Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 65. Brazil Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 66. Chile Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 67. Chile Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 68. Chile Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 69. MEA Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn
Table 70. UAE Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 71. UAE Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 72. UAE Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 73. Saudi Arabia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 74. Saudi Arabia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 75. Saudi Arabia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 76. South Africa Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn
Table 77. South Africa Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn
Table 78. South Africa Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn
Table 79. ACG Group: Company Snapshot
Table 80. ACG Group: Business Segmentation
Table 81. ACG Group: Product Portfolio
Table 82. ACG Group: Revenue, 2016-2018, $ mn
Table 83. ACG Group: Recent Developments
Table 84. Risk Evaluation for Investing in Global Market, 2019-2030
Table 85. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Pharmaceutical Continuous Manufacturing Market
Figure 8. Primary Restraints and Impact Factors of Global Pharmaceutical Continuous Manufacturing Market
Figure 9. Investment Opportunity Analysis
Figure 10. Porter’s Fiver Forces Analysis of Global Pharmaceutical Continuous Manufacturing Market
Figure 11. Breakdown of Global Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue
Figure 12. Global Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)
Figure 13. Global Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn
Figure 14. Global Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn
Figure 15. Global Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn
Figure 16. Global Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn
Figure 17. Global Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn
Figure 18. Global Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn
Figure 19. Global Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn
Figure 20. Global Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn
Figure 21. Global Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn
Figure 22. Breakdown of Global Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue
Figure 23. Global Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)
Figure 24. Global Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn
Figure 25. Global Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn
Figure 26. Global Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn
Figure 27. Global Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn
Figure 28. Breakdown of Global Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue
Figure 29. Global Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)
Figure 30. Global Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn
Figure 31. Global Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn
Figure 32. Global Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn
Figure 33. Global Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn
Figure 34. Global Market Snapshot by Region
Figure 35. Geographic Spread of Worldwide Pharmaceutical Continuous Manufacturing Market, 2019-2030, % of Sales Revenue
Figure 36. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%)
Figure 37. Health Spending as a Share of GDP by Country, 2015 and 2030
Figure 38. North American Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 39. Breakdown of North America Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 40. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 41. U.S. Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 42. Canada Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 43. Pharmaceutical Continuous Manufacturing Market in Mexico, 2015-2030, $ mn
Figure 44. European Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 45. Breakdown of European Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 46. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 47. Pharmaceutical Continuous Manufacturing Market in Germany, 2019-2030, $ mn
Figure 48. Pharmaceutical Continuous Manufacturing Market in UK, 2019-2030, $ mn
Figure 49. Pharmaceutical Continuous Manufacturing Market in France, 2019-2030, $ mn
Figure 50. Pharmaceutical Continuous Manufacturing Market in Spain, 2019-2030, $ mn
Figure 51. Pharmaceutical Continuous Manufacturing Market in Italy, 2019-2030, $ mn
Figure 52. Pharmaceutical Continuous Manufacturing Market in Russia, 2019-2030, $ mn
Figure 53. Pharmaceutical Continuous Manufacturing Market in Rest of Europe, 2019-2030, $ mn
Figure 54. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 55. Breakdown of APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 56. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 57. Pharmaceutical Continuous Manufacturing Market in Japan, 2019-2030, $ mn
Figure 58. Pharmaceutical Continuous Manufacturing Market in China, 2019-2030, $ mn
Figure 59. Pharmaceutical Continuous Manufacturing Market in Australia, 2019-2030, $ mn
Figure 60. Pharmaceutical Continuous Manufacturing Market in India, 2019-2030, $ mn
Figure 61. Pharmaceutical Continuous Manufacturing Market in South Korea, 2019-2030, $ mn
Figure 62. Pharmaceutical Continuous Manufacturing Market in Rest of APAC, 2019-2030, $ mn
Figure 63. South America Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn
Figure 64. Breakdown of South America Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 65. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 66. Pharmaceutical Continuous Manufacturing Market in Argentina, 2019-2030, $ mn
Figure 67. Pharmaceutical Continuous Manufacturing Market in Brazil, 2019-2030, $ mn
Figure 68. Pharmaceutical Continuous Manufacturing Market in Chile, 2019-2030, $ mn
Figure 69. Pharmaceutical Continuous Manufacturing Market in Rest of South America, 2019-2030, $ mn
Figure 70. Pharmaceutical Continuous Manufacturing Market in MEA, 2019-2030, $ mn
Figure 71. Breakdown of MEA Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue
Figure 72. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 73. Pharmaceutical Continuous Manufacturing Market in UAE, 2019-2030, $ mn
Figure 74. Pharmaceutical Continuous Manufacturing Market in Saudi Arabia, 2019-2030, $ mn
Figure 75. Pharmaceutical Continuous Manufacturing Market in South Africa, 2019-2030, $ mn
Figure 76. Growth Stage of Global Pharmaceutical Continuous Manufacturing Industry over the Forecast Period

COMPANIES MENTIONED

ACG Group
Alexanderwerk
Baker Perkins Ltd.
Coperion GmbH
Fette Compacting
Freund-vector Corporation
GEA Group AG
Gebrьder Lцdige Maschinenbau GmbH
Gericke AG
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
Leistritz AG
Munson Machinery Company, Inc.
Powrex Corp
Scott Equipment Company
Sturtevant, Inc.
Thermo Fisher Scientific Inc.